Santa Cruz Biotechnology delivers a wide array of FAM44A monoclonal antibodies for investigating FAM44A protein function and expression. FAM44A monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FAM44A, or Family with Sequence Similarity 44 Member A, plays essential roles in cell cycle regulation and apoptosis. Research has shown that FAM44A expression levels correlate with various disease states, particularly in cancer development and progression. Understanding FAM44A function and regulation can reveal new therapeutic strategies and potential biomarkers. Researchers can utilize FAM44A monoclonal antibodies to examine protein localization, expression patterns, and molecular interactions. Advanced visualization options include secondary antibodies conjugated to horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC). Current studies focus on mapping FAM44A signaling pathways and identifying novel binding partners. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of FAM44A's role in health and disease.